Skip to main content

Table 4 Association between Individual Frailty Components and ZAG or Adiponectin

From: Correlation between plasma ZAG and adiponectin in older adults: gender modification and frailty specificity

Variable

All participants

Male (n = 91)

Female (n = 98)

Estimate

SE

p-value*

Estimate

SE

p-value**

Estimate

SE

p-value**

Log (ZAG (μg/ml))

 Weight loss (Yes vs No)

0.02114

0.02754

0.4439

0.00616

0.04443

0.8901

0.04177

0.03251

0.2026

 Exhaustion (Yes vs No)

0.02483

0.01813

0.1727

0.01100

0.03074

0.7214

0.03633

0.02017

0.0755

 Low physical activity (Yes vs No)

−0.04863

0.03914

0.2158

−0.09031

0.06459

0.1660

−0.00277

0.04535

0.9515

 Slow walking speed (Yes vs No)

0.02040

0.01820

0.2638

−0.00151

0.03150

0.9619

0.03918

0.02032

0.0574

 Weakness (Yes vs No)

0.01680

0.01791

0.3495

0.02908

0.02901

0.3192

−0.00294

0.02172

0.8927

Log (Adiponectin Levels (μg/mL))

 Weight loss (Yes vs No)

0.12392

0.06147

0.0454

0.05998

0.07566

0.4303

0.19057

0.09785

0.0550

 Exhaustion (Yes vs No)

0.01041

0.04220

0.8054

0.06142

0.05213

0.2423

−0.03720

0.06595

0.5743

 Low physical activity (Yes vs No)

0.09166

0.09086

0.3146

0.18168

0.10989

0.1023

−0.01318

0.14609

0.9283

 Slow walking speed (Yes vs No)

0.06625

0.04190

0.1158

−0.01401

0.05383

0.7954

0.13107

0.06479

0.0464

 Weakness (Yes vs No)

0.08330

0.04126

0.0451

0.10670

0.04843

0.0305

0.04823

0.07030

0.4947

  1. Note: ZAG zinc alpha2-glycoprotein; BMI body mass index; DM diabetes mellitus
  2. *Adjust for age, gender, BMI, DM
  3. ** Adjust for age, BMI, DM